Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30,443 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an Inventory of Dental Harms: Methods and Rationale.
Kalenderian E, Lee JH, Obadan-Udoh EM, Yansane A, White JM, Walji MF. Kalenderian E, et al. Among authors: lee jh. J Patient Saf. 2022 Sep 1;18(6):559-564. doi: 10.1097/PTS.0000000000001033. Epub 2022 Jun 30. J Patient Saf. 2022. PMID: 35771964 Free PMC article. Review.
Assessing the Patient Safety Culture in Dentistry.
Yansane A, Lee JH, Hebballi N, Obadan-Udoh E, White J, Walji M, Easterday C, Rindal B, Worley D, Kalenderian E. Yansane A, et al. Among authors: lee jh. JDR Clin Trans Res. 2020 Oct;5(4):399-408. doi: 10.1177/2380084419897614. Epub 2020 Jan 10. JDR Clin Trans Res. 2020. PMID: 31923373
Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as A2A Adenosine Receptor Antagonists: Exploring the Roles of Ribose at Adenosine Receptors.
Kim G, Jarhad DB, Lee G, Kim G, Hou X, Yu J, Lee CS, Warnick E, Gao ZG, Ahn SY, Kwak D, Park K, Lee SD, Park TU, Jung SY, Lee JH, Choi JR, Kim M, Kim D, Kim B, Jacobson KA, Jeong LS. Kim G, et al. Among authors: lee jh. J Med Chem. 2024 Jun 6. doi: 10.1021/acs.jmedchem.4c01003. Online ahead of print. J Med Chem. 2024. PMID: 38845345
Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: Results of the multicenter KMMWP2201 study.
Lee JH, Choi J, Min CK, Park SS, Jo JC, Lee YJ, Kim JS, Eom HS, Jung J, Moon JH, Cho HJ, Lee MW, Yoon SS, Byun JM, Lee JH, Lee JJ, Jung SH, Shin HJ, Kim DY, Yi JH, Lee SS, Do YR, Yoon DH, Cho H, Lee WS, Lee HS, Uhm J, Kim HJ, Jang HR, Kim SH, Kim K. Lee JH, et al. Haematologica. 2024 Jun 6. doi: 10.3324/haematol.2024.285534. Online ahead of print. Haematologica. 2024. PMID: 38841794 Free article.
30,443 results
You have reached the last available page of results. Please see the User Guide for more information.